Based on computed tomography scan data a complementary immunohistochemical investigations were performed and they revealed that tumor cells exhibited a loss of expression of both SMARCA4 and SMARCA2 while SMARCB1 was retained (Fig. 3a, b). Here, SMARCA4 is linked to neoplasm.